Article Details

FDA Extends Review Period For AstraZeneca-Merck Partnered Cancer Drug ... - Yahoo Finance

Retrieved on: 2022-12-15 13:24:03

Tags for this article:

Click the tags to see associated articles and topics

FDA Extends Review Period For AstraZeneca-Merck Partnered Cancer Drug ... - Yahoo Finance. View article details on hiswai:

Excerpt

The FDA will extend the Prescription Drug User Fee Act (PDUFA) date for AstraZeneca Plc (NASDAQ: AZN) and Merck & Co Inc's (NYSE: MRK) ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up